Morgan Stanley Maintains Equal-Weight on Organon, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Organon (NYSE:OGN) and lowered the price target from $27 to $22.
October 11, 2023 | 2:37 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Organon and lowered the price target from $27 to $22.
The lowering of the price target by Morgan Stanley indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Organon's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100